...continuation. The company announced plans to merge with robotics company Microbot Medical Ltd. in August. Macrocure Ltd....
...Los Angeles, Calif. Leap Therapeutics Inc., Cambridge, Mass. London Project to Cure Blindness, London, U.K. Macrocure Ltd....
...Institute for Regenerative Medicine (CIRM) Charles River Laboratories International Inc. City of Hope Fate Therapeutics Inc. Harvard University Leap Therapeutics Inc. Macrocure Ltd. Massachusetts...

...presented at the European Society for Medical Oncology meeting in Copenhagen. Leap is merging with Macrocure Ltd....

...Leap will merge with Macrocure in a deal that will create a publicly listed company with...
...TNFR)-related protein (GITR; TNFRSF18 ), is in Phase I development for solid tumors. Last August, Macrocure...
...treat venous leg ulcers. Leap shareholders will own about 68% of the combined company and Macrocure...

...Leap Therapeutics Inc. (Cambridge, Mass.) is merging with Macrocure Ltd. (NASDAQ:MCUR) in a deal that will create...
...development for solid tumors. Leap shareholders will own about 68% of the combined company and Macrocure...
...will invest $10 million in the merged company. Raymond James is advising Macrocure. Last August, Macrocure's...

...for 4 additional weeks and with >=50% target ulcer closure during treatment vs. sham controls. Macrocure Ltd....

...NASDAQ:KPTI) Selinexor fails in the Phase II SOPRA trial to treat acute myelogenous leukemia (AML) Macrocure Ltd....

...4Q15 a Phase III trial of the ATP citrate lyase (ACLY) inhibitor in the indication. Macrocure Ltd....
...said the futility finding is "surprising" given the "healthy real world" experience in Israel, where Macrocure...

...a Phase III trial of CureXcell to treat diabetic foot ulcers are expected in October. Macrocure...

...100% wound closure at 12 weeks and sustained complete closure for four additional weeks (p≤0.05). Macrocure...
...containing activated allogeneic white blood cells isolated from the peripheral blood of healthy allogeneic donors. Macrocure...